Lazard Asset Management
MED icon

Lazard Asset Management’s Medifast MED Stock Holding History

Lazard Asset Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-205
Closed -$13K – 2244
2023
Q4 		$13K Sell
205
-1,288
-86% -$89.7K ﹤0.01% 2082
2023
Q3 		$111K Buy
1,493
+297
+25% +$26.3K ﹤0.01% 1594
2023
Q2 		$110K Sell
1,196
-6,874
-85% -$612K ﹤0.01% 1545
2023
Q1 		$836K Buy
8,070
+7,264
+901% +$805K ﹤0.01% 1039
2022
Q4 		$92K Hold
806
– – ﹤0.01% 1558
2022
Q3 		$87K Buy
806
+6
+0.8% +$860 ﹤0.01% 1528
2022
Q2 		$144K Buy
800
+210
+36% +$37.6K ﹤0.01% 1368
2022
Q1 		$100K Sell
590
-10,733
-95% -$2.02M ﹤0.01% 1397
2021
Q4 		$2.37M Sell
11,323
-4,524
-29% -$935K ﹤0.01% 905
2021
Q3 		$3.05M Buy
15,847
+2,486
+19% +$611K ﹤0.01% 855
2021
Q2 		$3.78M Buy
13,361
+7,203
+117% +$1.95M ﹤0.01% 762
2021
Q1 		$1.3M Buy
6,158
+5,588
+980% +$1.34M ﹤0.01% 862
2020
Q4 		$111K Buy
570
+29
+5% +$5.13K ﹤0.01% 1169
2020
Q3 		$88K Sell
541
-37,764
-99% -$6.22M ﹤0.01% 1042
2020
Q2 		$5.32M Buy
38,305
+37,284
+3,652% +$3.42M 0.01% 561
2020
Q1 		$63K Buy
1,021
+310
+44% +$28.2K ﹤0.01% 1109
2019
Q4 		$77K Buy
711
+466
+190% +$45.1K ﹤0.01% 988
2019
Q3 		$25K Sell
245
-11,684
-98% -$1.26M ﹤0.01% 1047
2019
Q2 		$1.53M Sell
11,929
-85
-0.7% -$11.8K ﹤0.01% 783
2019
Q1 		$1.53M Buy
12,014
+123
+1% +$15.6K ﹤0.01% 778
2018
Q4 		$1.49M Sell
11,891
-8,382
-41% -$1.43M ﹤0.01% 669
2018
Q3 		$4.49M Hold
20,273
– – 0.01% 587
2018
Q2 		$3.25M Buy
+20,273
New +$2.59M 0.01% 615

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Lazard Asset Management's MED Position: Q1 2024 in Review

Lazard Asset Management sold out of Medifast (MED) in Q1 2024, closing a stake of 205 shares — an estimated $13K sold.

Lazard Asset Management first reported a position in MED in Q2 2018 and held it in 23 quarters. The position peaked at $5.32M in Q2 2020. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

  • Lazard Asset Management reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
  • Lazard Asset Management sold 205 Medifast shares in Q1 2024, an estimated $13K.
  • Lazard Asset Management first reported a position in Medifast in Q2 2018 and held it in 23 quarters.
  • Lazard Asset Management's Medifast position peaked at $5.32M in Q2 2020.
  • 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Lazard Asset Management's 13F filing for Q1 2024, filed 14 May 2024.